Stock EXAS EXACT SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
53.52 USD +4.94% Intraday chart for Exact Sciences Corporation -0.89% -27.66%
May. 21 Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed MT
May. 15 Transcript : Exact Sciences Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed
MT
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
BU
Exact Sciences : TCFD Report for the FY ended 12/29/2021
PU
Foundation Fighting Blindness Partners with PreventionGenetics and InformedDNA to Advance My Retina Tracker Genetic Testing Program
AQ
Transcript : Exact Sciences Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM
Exact Sciences : Names Aaron Bloomer as New Chief Financial Officer
PU
Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours
MT
Exact Sciences: Q1 Earnings Snapshot
AQ
Transcript : Exact Sciences Corporation, Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M
MT
Exact Sciences Announces First-Quarter 2024 Results
BU
Exact Sciences Corporation Maintains Revenue Guidance for the Full Year of 2024
CI
Exact Sciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
BU
Exact Sciences : ESG Report for the FY ended 12/31/2023
PU
Exact Sciences : SASB Index for the FY ended 12/30/2023
PU
Exact Sciences : TCFD Report for the FY ended 12/29/2023
PU
Exact Sciences to Participate in May Investor Conference
BU
Exact Sciences Corporation Announces Board Resignations
CI
Exact Sciences Corporation announced that it has received $266.75 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. News Exact Sciences Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW